Abstract: Several highly substituted imidazoles have been under investigation at GlaxoSmithKline as potential therapies for the treatment of rheumatoid arthritis and have spawned the need for a general synthetic method for their preparation on a multikilogram scale. We describe herein the optimization of a general method for the preparation of arylsubstituted TosMIC reagents and the ease with which they undergo [3+2] cycloadditions with a host of imines, prepared in situ, to generate densely functionalized imidazoles with various substitution patterns in a completely regioselective manner.
gave yields of less than 50 %, and the ArS-moiety that is ejected during the product-forming step displaced the aryl fluoride in low levels, leading to impurities that were very difficult to remove. Although the literature [2] had suggested that several of these drawbacks could be eliminated by working through the corresponding sulfone (Fig. 2 , where n = 2), a practical method to prepare this compound remained elusive. We describe in this report efficient and scaleable processes for making the desired sulfonyl isonitriles as well as their utility in preparing multifunctional, polysubstituted imidazoles.
DEVELOPING A PROCESS FOR MAKING ARYL-SUBSTITUTED TosMIC REAGENTS
We have previously described a new procedure for preparing aryl-substituted TosylMethyl IsoCyanides (TosMIC) precursors [3] and the use of the corresponding TosMIC reagents for the preparation of target imidazole A in a one-pot procedure (Scheme 1) [4] . However, an interesting thing happened during the scale-up of the process for making formamide 2. Although we achieved the expected yield, a 1-2 % impurity was found by HPLC that was later identified as the reduced version of the target molecule (4a). To our surprise, we quickly determined that there was none of the corresponding "defluorinated" con- taminant in the 4-fluorobenzaldehyde or in the bis-formamide (1). After considerable detective work, we've learned that the presence of 4a arises from oxidation of our solvent (toluene) in the presence of O 2 and toluenesulfinic acid. This was confirmed by conducting the same reaction in a p-xylene/acetonitrile solvent mixture and finding 1-2 % of the p-methylated derivative (4b) in the product mixture.
Scaling up the dehydration of formamide 2 to the TosMIC reagent 5 posed a different set of problems. Experimentally, the reaction is quite simple, involving the addition of excess Et 3 N to a suspension of formamide in THF containing two equivalents of POCl 3 . However, evaluation of the process safety data, in particular the accelerating rate calorimetry (ARC) data (Fig. 3) , showed that the product decomposes violently as temperatures approach 80 °C. Although this was initially disconcerting, we have safely produced in excess of 500 kg of isonitrile 5 by keeping the reaction temperature near 0 °C during the Et 3 N addition and during the water quench. Once isolated, the isonitrile 5 is a stable, crystalline solid that is very easily handled.
DEVELOPMENT ROUTES TO IMIDAZOLES C AND D
We have previously described the synthesis of target molecule A [4] , and imidazole B can be easily prepared from readily accessible starting materials. For these reasons, the discussion below is focused on the last two targets, C and D, which provided some of the more significant challenges for scale-up. Although the two retrosynthetic pathways below may look similar (Fig. 4) , the changes we introduced made the difference between grams and kilograms.
By the time these compounds were discovered, our medicinal chemistry colleagues were using our TosMIC reagent for their discovery efforts with good success (Fig. 4) [5] . Following procedures developed in our labs [4] , the aldehyde and amine were combined in DMF prior to adding the TosMIC reagent and K 2 CO 3 to give product in 60-70 % yield. While the TosMIC reagent was obtained from our previous work on imidazole A, the second component, aminopiperidine 6, was readily accessible from
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General process for the synthesis of highly substituted imidazoles 1351 4-piperidone, albeit in three synthetic stages. Unfortunately, a quick evaluation of the final component, aldehyde 7, revealed that it had several features that made it unattractive for scale-up.
The most direct route to this pyrimidine aldehyde was through the general procedure first described by Bredereck [6] . Heating neat pyruvaldehyde dimethyl acetal and N,N-dimethylformamide dimethyl acetal generates the vinylogous amide 10 (Scheme 2). Without isolation, 10 was treated with urea and base, but none of the desired pyrimidone was isolated. Replacing urea with O-methyl isourea (11) and heating with K 2 CO 3 in EtOH generated the desired product, 12a. However, the product was contaminated with equal amounts of the ethoxy derivative 12b and the N,N-dimethyl derivative 12c, each presumably arising from displacement of the methoxy group of 12a by the other nucleophiles present in the reaction mixture. Since neither of these options looked feasible, we looked to prepare the desired compound by way of the more stable thioalkyl pyrimidines. Thus, heating vinylogous amide 10 with S-methyl pseudothiourea (13) in MeOH with NaOMe generated thiomethyl pyrimidine 14. However, the stench associated with this reaction was so noxious that it was obviously unsuitable for scale-up. We circumvented this problem by going in a stepwise fashion, first treating 10 with thiourea in base to generate the thiopyrimidine compound which could be smoothly alkylated with 1-PrBr to generate 15 in 70-75 % yield in a one-pot process. Oxidation of the sulfide using Oxone ® [7] , followed by displacement of the sulfone moiety, cleanly gave the 2-methoxypyrimidine acetal 12a. Unfortunately, hydrolysis of the acetal moiety of 12a produced the desired aldehyde 7 that was difficult to isolate owing to its appreciable water solubility, and that was also prone to displacement at the 2-position. Although aldehyde 7 was, in fact, a reliable partner for making target molecule C, its drawbacks for large-scale production greatly outweighed its advantages.
While considering our options for developing a scaleable process for the synthesis of C, we found that the carboxyethyl piperidine 8 was commercially available at a reasonable price, saving three synthetic steps. However, given the challenges mentioned above for the synthesis of aldehyde 7 and its known instability at the 2-position under conditions that would be required to remove the ethyl carbamate function, we soon recognized the need for a different approach for introducing the methoxypyrimidine group. The successful approach is highlighted in Scheme 3.
2-Thioalkyl pyrimidines are known to be considerably more stable than their alkoxy derivatives and we had already demonstrated a one-pot synthesis of 15, making it an attractive starting point. Hydrolysis of the acetal function of 15 with 3N HCl gave the aldehyde 9. Without isolation of the aldehyde, we added aminopiperidine 8 and EtOAc to the reaction mixture. Adjusting the pH to 8 with NaOH induced rapid formation of imine 16, which separated into the organic layer. After separation of the aqueous layer, TosMIC reagent 5 and piperazine were added, which led to clean formation of the imidazole product 17 in 60-65 % isolated yield, even at a 200-gallon scale. groups and water [4] , was demonstrated by smooth, one-pot conversion of imine 21 to imidazole 22 promoted by mild bases like piperazine. The product 22 was separated cleanly from the other organic components by adding 4N HCl and collecting the aqueous layer. To this was added Na 2 WO 4 ·2H 2 O (1 mole %) and excess 30 % H 2 O 2 [8] , which smoothly and quantitatively oxidized the sulfide to the corresponding sulfone. After quenching any residual peroxide, the solution was diluted with MeOH and made basic with 50 % NaOH to pH 8-9 to induce displacement of the sulfone by -OMe to produce the target molecule. Upon cooling to 0°C, the product crystallized from solution and was isolated with >96 % purity. Remarkably, this one-pot process delivered the product in 55-65 % isolated yield, based on isonitrile 5.
One final approach to C that was briefly investigated is presented in Scheme 6. Although we had discounted using 2-methoxypyrmidine aldehyde 7 because of, among other things, its appreciable water solubility as discussed above, we continued to explore possible avenues for its use in order to limit the number of post-imidazole transformations. As such, we conceived and briefly explored the chemistry shown in Scheme 6. Hydrolysis of the acetal moiety in 12a leads to smooth conversion to the aldehyde 7, as noted above. Although 7 itself is quite water-soluble and difficult to isolate, we found that adjusting the pH to 8-9 and adding t-BuNH 2 and EtOAc quickly and cleanly leads to the imine 23, which has virtually no water solubility and is easily extracted into the EtOAc in 80 % overall yield. Addition of 4-aminopiperidine (20) to a toluene solution of 23 at reflux for several hours induced trans-imination, driven by removal of the volatile by-product, tert-BuNH 2 . After cooling to ambient temperature and adding EtOAc, TosMIC 5, and piperazine, HPLC analysis of the product mixture showed the desired product C and t-Bu imidazole 24 in a 92:8 ratio. Although this route clearly merited further examination, the project was terminated before we had the chance to do so.
With the successes found in the schemes shown above, devising a practical route to the final target, imidazole D, was a fairly simple task (Scheme 7). Hydrolysis of acetal 15 with 3N HCl led to the aldehdye 9, which, after neutralization, was extracted into EtOAc and treated directly trans-4-aminocyclohexanol. To the solution of imine 25 that was produced was added isonitrile 5, DMF, and K 2 CO 3 to give imidazole 26 in 60 % isolated yield in a single pot from acetal 15. Completing the synthesis involved oxidation of the sulfide with Oxone in MeOH/H 2 O, then adjusting the pH to 8-9 to induce -OMe displacement of the sulfur group, which was accomplished in a single operation in 90 % yield. (1)
In summary, we have described a highly efficient method for preparing a variety of imidazoles compounds in a one-pot, multicomponent reaction sequence. Yields are uniformly high, reaction conditions are quite mild, and the transformations are experimentally simple. In addition, functional group compatibility is excellent, and introduction of asymmetric centers from chiral amines or aldehydes (not shown) can easily be accomplished.
